These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26857656)

  • 1. Liposomes as potential masking agents in sport doping. Part 1: analysis of phospholipids and sphingomyelins in drugs and biological fluids by aqueous normal-phase liquid chromatography-tandem mass spectrometry.
    Esposito S; Colicchia S; de la Torre X; Mazzarino M; Botrè F
    Drug Test Anal; 2017 Jan; 9(1):75-86. PubMed ID: 26857656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and Reliable Identification of Phospholipids for Untargeted Metabolomics with LC-ESI-QTOF-MS/MS.
    Godzien J; Ciborowski M; Martínez-Alcázar MP; Samczuk P; Kretowski A; Barbas C
    J Proteome Res; 2015 Aug; 14(8):3204-16. PubMed ID: 26080858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
    Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
    Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of urinary phospholipids found in patients with breast cancer by nanoflow liquid chromatography-tandem mass spectrometry: II. Negative ion mode analysis of four phospholipid classes.
    Min HK; Kong G; Moon MH
    Anal Bioanal Chem; 2010 Feb; 396(3):1273-80. PubMed ID: 19937430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes.
    Mazzarino M; Cesarei L; de la Torre X; Fiacco I; Robach P; Botrè F
    J Pharm Biomed Anal; 2016 Jan; 117():47-60. PubMed ID: 26342446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous profiling of lysophospholipids and phospholipids from human plasma by nanoflow liquid chromatography-tandem mass spectrometry.
    Lee JY; Min HK; Moon MH
    Anal Bioanal Chem; 2011 Jul; 400(9):2953-61. PubMed ID: 21499968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High performance liquid chromatography-tandem mass spectrometry of phospholipid molecular species in eggs from hens fed diets enriched in seal blubber oil.
    Pacetti D; Boselli E; Hulan HW; Frega NG
    J Chromatogr A; 2005 Dec; 1097(1-2):66-73. PubMed ID: 16298186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel artificial liquid membrane extraction as an efficient tool for removal of phospholipids from human plasma.
    Ask KS; Bardakci T; Parmer MP; Halvorsen TG; Øiestad EL; Pedersen-Bjergaard S; Gjelstad A
    J Pharm Biomed Anal; 2016 Sep; 129():229-236. PubMed ID: 27433988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects.
    Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2125-38. PubMed ID: 19517478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry.
    Taguchi R; Hayakawa J; Takeuchi Y; Ishida M
    J Mass Spectrom; 2000 Aug; 35(8):953-66. PubMed ID: 10972995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
    Rzeppa S; Viet LN
    Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry.
    Kerwin JL; Tuininga AR; Ericsson LH
    J Lipid Res; 1994 Jun; 35(6):1102-14. PubMed ID: 8077849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control.
    Kwok WH; Choi TLS; Tsoi YYK; Leung GNW; Wan TSM
    J Chromatogr A; 2017 Mar; 1490():89-101. PubMed ID: 28215405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of phospholipids in infant formulas using high performance liquid chromatography-tandem mass spectrometry.
    Fong B; Ma L; Norris C
    J Agric Food Chem; 2013 Jan; 61(4):858-65. PubMed ID: 23297796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
    Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
    J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient hydrophilic interaction liquid chromatography separation of 7 phospholipid classes based on a diol column.
    Zhu C; Dane A; Spijksma G; Wang M; van der Greef J; Luo G; Hankemeier T; Vreeken RJ
    J Chromatogr A; 2012 Jan; 1220():26-34. PubMed ID: 22169191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional and molecular species analysis of phospholipids by high performance liquid chromatography coupled with chemical ionization mass spectrometry.
    Jungalwala FB; Evans JE; McCluer RH
    J Lipid Res; 1984 Jul; 25(7):738-49. PubMed ID: 6481246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
    Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
    Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single run LC-MS/MS method for phospholipidomics.
    Buré C; Ayciriex S; Testet E; Schmitter JM
    Anal Bioanal Chem; 2013 Jan; 405(1):203-13. PubMed ID: 23064709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.